Financials in USD. Standardized financial statements.
A compact view of how IGC Pharma, Inc. turns revenue into operating income and net income.
| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.19M | $1.27M | $1.34M | $911,000 | $397,000 | $898,000 | $4.07M | $5.12M | $2.19M | $580,372 |
| Revenue Growth? | -6.7% | -5.5% | +47.6% | +129.5% | -55.8% | -77.9% | -20.4% | +133.3% | +277.9% | 0.0% |
| Cost of Revenue? | $834,000 | $652,000 | $612,000 | $1.07M | $203,000 | $1.25M | $3.96M | $4.98M | $2.11M | $362,135 |
| Gross Profit? | $352,000 | $619,000 | $733,000 | -$158,000 | $194,000 | -$349,000 | $115,000 | $132,000 | $81,524 | $218,237 |
| Gross Margin? | +29.7% | +48.7% | +54.5% | -17.3% | +48.9% | -38.9% | +2.8% | +2.6% | +3.7% | +37.6% |
| Operating Expenses? | $10.55M | $8.06M | $10.53M | $11.41M | $15.62M | $8.38M | $6.98M | $4.78M | $1.87M | $2.27M |
| Operating Income? | -$10.20M | -$7.45M | -$9.80M | -$11.57M | -$15.43M | -$8.72M | -$6.86M | -$4.64M | -$1.79M | -$2.05M |
| EBITDA? | -$9.88M | -$6.98M | -$9.16M | -$10.85M | -$14.37M | -$8.33M | -$6.72M | -$4.58M | -$1.74M | -$1.22M |
| Income Before Tax | -$6.55M | -$7.12M | -$13.00M | -$11.51M | -$15.02M | -$8.81M | -$7.32M | -$4.09M | -$1.79M | -$1.84M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2,000 | $464 | $14,431 |
| Net Income? | -$6.55M | -$7.12M | -$13.00M | -$11.51M | -$15.02M | -$8.81M | -$7.32M | -$4.10M | -$1.79M | -$1.87M |
| EPS? | $-0.07 | $-0.09 | $-0.22 | $-0.22 | $-0.30 | $-0.21 | $-0.19 | $-0.12 | $-0.06 | $-0.07 |
| Diluted EPS? | $-0.07 | $-0.09 | $-0.22 | $-0.22 | $-0.30 | $-0.21 | $-0.19 | $-0.12 | $-0.06 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality